A 2-Year Multi-Centre, Open-Label, Local Phase IV Study to Demonstrate the Efficacy and Safety of Adefovir Dipivoxil Tablets (10mg) in Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B.
Phase of Trial: Phase IV
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Adefovir dipivoxil (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 12 Mar 2009 Actual patient number (533) added as reported by ClinicalTrials.gov.
- 12 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Feb 2008 Planned end date (Jan 2009) added as reported by ClinicalTrials.gov.